CIPROFLOXACIN CONCENTRATE FOR IN. Key specifications include special_features: CONTAINS 1 PERCENT AQUEOUS CONCENTRATE OF CIPROFLOXACIN; FOR INTRAVENOUS USE, primary_container_type: VIAL, total_primary_container_quantity: 60, primary_container_content_quantity: 20.000 MILLILITERS, active_medicament_medicinal_strength: 200.000 MILLIGRAMS CIPROFLOXACIN EQUIVALENT, part_name_assigned_by_controlling_agency: CIPROFLOXACIN CONCENTRATE FOR INJECTION 20ML VIAL 60S. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System under NSN 6505-01-337-3124, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | CONTAINS 1 PERCENT AQUEOUS CONCENTRATE OF CIPROFLOXACIN; FOR INTRAVENOUS USE |
| primary_container_type | VIAL |
| total_primary_container_quantity | 60 |
| primary_container_content_quantity | 20.000 MILLILITERS |
| active_medicament_medicinal_strength | 200.000 MILLIGRAMS CIPROFLOXACIN EQUIVALENT |
| part_name_assigned_by_controlling_agency | CIPROFLOXACIN CONCENTRATE FOR INJECTION 20ML VIAL 60S |
| NSN | 6505-01-337-3124 |
| PRIMARY CONTAINER TYPE | VIAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 20.000 MILLILITERS |
| SPECIAL FEATURES | CONTAINS 1 PERCENT AQUEOUS CONCENTRATE OF CIPROFLOXACIN; FOR INTRAVENOUS USE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CIPROFLOXACIN CONCENTRATE FOR INJECTION 20ML VIAL 60S |
| TOTAL PRIMARY CONTAINER QUANTITY | 60 |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 200.000 MILLIGRAMS CIPROFLOXACIN EQUIVALENT |